HARDEEP SINGH TULI, GAURAV KUMAR, SARDUL SINGH SANDHU, ANIL KUMAR SHARMA, DHARMBIR KASHYAP

Apoptotic effect of cordycepin on A549 human lung cancer cell line

Cordycepin, an active ingredient in the insect fungus Cordyceps militaris, is in a category of compounds that exhibit significant therapeutic activity. The aim of the present study was to investigate the effect of cordycepin on cell proliferation, apoptosis, and cell cycle in A549 human lung cancer cells. MTT assay was used to evaluate the cytotoxic effect of cordycepin on A549 cell growth. Apoptotic effect was observed using cell morphology, DAPI staining, and DNA fragmentation studies. Flow cytometry (FCM) analysis was used to analyze cell cycle status after cordycepin treatment. Furthermore, apoptosis was assayed using annexin V-Alexa Fluor 488. Results of MTT assay showed that cordycepin significantly inhibited cell proliferation with an IC50 value of 64 µg/mL. The number of rounding-up cells increased with cordycepin treatment and changes in cellular morphology were seen. In DNA fragmentation studies, a typical ladder pattern was observed on agarose gel and formation of apoptotic bodies was further confirmed using DAPI staining. The FCM analysis of cordycepin-treated cells showed that apoptosis rate increased with the increase in dosage. In conclusion, cordycepin induces apoptosis in A549 human lung cancer cell line and could be a potential therapeutic candidate for lung cancer treatment.

Anahtar Kelimeler:

Cordyceps militaris, cordycepin, lung cancer, flow cytometry, cell cycle, apoptosis

Apoptotic effect of cordycepin on A549 human lung cancer cell line

Keywords:

Cordyceps militaris, cordycepin, lung cancer, flow cytometry, cell cycle, apoptosis,

PDF

___

Cunningham KG, Manson W, Spring FS, Hutchinson SA (1950). Cordycepin, a metabolic product isolated from cultures of Cordyceps militaris (Linn.) Link. Nature 166: 949–954.
Danesi R, Braud FD, Fogli S, Depas TMD, Paolo AD, Curigliano G, Tacca MD (2003). Pharmaco-genetics of anticancer drug sensitivity in non-small cell lung cancer. Pharmacol Rev 55: 57–103.
Douillard JY, Lerouge D, Monnier A, Bennouna J, Haller AM, Sun XS, Assouline D, Grau B, Rivière A (2001). Combined paclitaxel and gemcitabine as first-line treatment in metastatic non-small cell lung cancer: a multicentre phase II study. Br J Cancer 84: 1179–1184.
Jemal A, Siegel R, Xu J, Ward E (2010). Cancer statistics. CA Cancer J Clin 60: 277–300.
Kim PK, Park SY, Koty PP, Hua Y, Luketich JD, Billiar TR (2003). Fas-associating death domain protein overexpression induces apoptosis in lung cancer cells. J Thorac Cardiovasc Surg 125: 1336–1342.
Koshkina NV, Waldrep JC, Knight V (2003). Camptothecins and lung cancer: improved delivery systems by aerosol. Curr Cancer Drug Targets 3: 251–264.
Kosty MP, Fleishman SB, Herndon JE, Coughlin K, Kornblith AB, Scalzo A, Morris JC, Mortimer J, Green MR (1994). Cisplatin, vinblastine, and hydrazine sulfate in advanced, non-small-cell lung cancer: a randomized placebo-controlled, double-blind phase III study of the cancer and leukemia group B. J Clin Oncol 12: 1113–1120.
Lee H, Kim YJ, Kim HW, Lee DH, Sung MK, Park T (2006). Induction of apoptosis by Cordyceps militaris through activation of caspase-3 in leukemia HL-60 cells. Biol Pharma Bull 29: 670– 674.
Lu H, Li X, Zhang J, Shi H, Zhu X, He X (2014). Effects of cordycepin on HepG2 and EA.hy926 cells: potential antiproliferative, antimetastatic and anti-angiogenic effects on hepatocellular carcinoma. Oncol Lett 7: 1556–1562.
Lui JC, Wong JW, Suen YK, Kwok TT, Fung KP, Kong SK (2007). Cordycepin induced eryptosis in mouse erythrocytes through a Ca2+ dependent pathway without caspase-3 activation. Arch Toxicol 81: 859–865.
Park C, Hong SH, Lee JY, Kim GY, Choi BT, Lee YT, Park DI, Park YM, Jeong YK, Choi YH (2005). Growth inhibition of U937 leukemia cells by aqueous extract of Cordyceps militaris through induction of apoptosis. Oncol Rep 13: 1211–1216.
Park SE, Yoo HS, Jin CY, Hong SH, Lee YW, Kim BW, Lee SH, Kim WJ, Cho CK, Choi YH (2009). Induction of apoptosis and inhibition of telomerase activity in human lung carcinoma cells by the water extract of Cordyceps militaris. Food Chem Toxicol 47: 1667–1675.
Paterson RR (2008). Cordyceps: a traditional Chinese medicine and another fungal therapeutic biofactory? Phytochemistry 69: 1469–1495.
Thakur A, Hui R, Hongyan Z, Tian Y, Tianjun C, Mingwei C (2011). Pro-apoptotic effects of Paecilomyces hepiali, a Cordyceps sinensis extract on human lung adenocarcinoma A549 cells in vitro. J Can Res Ther 7: 421–426.
Tuli HS, Sandhu SS, Kashyap D, Sharma AK (2014a). Optimization of extraction conditions and antimicrobial potential of a bioactive metabolite, cordycepin from Cordyceps militaris 3936. WJPPS 3: 1525–1535.
Tuli HS, Sandhu SS, Sharma AK (2014b). Pharmacological and therapeutic potential of Cordyceps with special reference to cordycepin. 3 Biotech 4: 1–12.
Tuli HS, Sandhu SS, Sharma AK, Kashyap D (2013). Cordycepin: a bioactive metabolite with therapeutic potential. Life Sci 93: 863–869.
Tuli HS, Sandhu SS, Sharma AK, Kashayap D (2014c). Anti- angiogenic activity of the extracted fermentation broth of an entomopathogenic fungus, Cordyceps militaris 3936. Int J Pharm Pharm Sci 6: 581–583.
Vejselova D, Kutlu HM (2015). Inhibitory effects of salicylic acid on A549 human lung adenocarcinoma cell viability. Turk J Biol 39: 1–5.
Wlodkowic D, Skommer J, Darzynkiewicz Z (2009). Flow cytometry- based apoptosis detection. Methods Mol Biol 559: 19–32.
Wu WC, Hsiao JR, Lian YY, Lin CY, Huang BM (2007). The apoptotic effect of cordycepin on human OEC-M1 oral cancer cell line. Cancer Chemother Pharmacol 60: 103–108.